Validation of a Predictive Model of Response to Romiplostim in Patients With IPSS Low or Intermediate-1 Risk MDS and Thrombocytopenia
Clinical trial NCT02335268 · COMPLETED
Trial details
- NCT number
- NCT02335268
- Sponsor
- Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-21
- Primary completion
- 2021-07-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.